Form 8-K - Current report:
SEC Accession No. 0001213900-24-091235
Filing Date
2024-10-28
Accepted
2024-10-28 16:55:45
Documents
14
Period of Report
2024-10-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0218797-8k_osthera.htm   iXBRL 8-K 36564
2 PRESS RELEASE ISSUED BY OS THERAPIES ON OCTOBER __, 2024 ea021879701ex99-1_osthera.htm EX-99.1 15112
  Complete submission text file 0001213900-24-091235.txt   237104

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ostx-20241028.xsd EX-101.SCH 3024
4 XBRL LABEL FILE ostx-20241028_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ostx-20241028_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0218797-8k_osthera_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 241401572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)